BMP Signaling Is Required for RUNX2-Dependent Induction of the Osteoblast Phenotype
Top Cited Papers
Open Access
- 1 April 2006
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Bone and Mineral Research
- Vol. 21 (4) , 637-646
- https://doi.org/10.1359/jbmr.060109
Abstract
RUNX2 expression in mesenchymal cells induces osteoblast differentiation and bone formation. BMP blocking agents were used to show that RUNX2‐dependent osteoblast differentiation and transactivation activity both require BMP signaling and, further, that RUNX2 enhances the responsiveness of cells to BMPs. Introduction: BMPs and the RUNX2 transcription factor are both able to stimulate osteoblast differentiation and bone formation. BMPs function by activating SMAD proteins and other signal transduction pathways to stimulate expression of many target genes including RUNX2. In contrast, RUNX2 induces osteoblast‐specific gene expression by directly binding to enhancer regions in target genes. In this study, we examine the interdependence of these two factors in controlling osteoblast differentiation in mesenchymal progenitor cells. Materials and Methods: C3H10T1/2 mesenchymal cells and primary cultures of marrow stromal cells were transduced with a RUNX2 adenovirus and treated with BMP blocking antibodies or the natural antagonist, NOGGIN. Osteoblast differentiation was determined by assaying alkaline phosphatase and measuring osteoblast‐related mRNA using quantitative RT/PCR. Activation of BMP‐responsive signal transduction pathways (SMAD, extracellular signal‐regulated kinase [ERK], p38, and c‐jun‐N‐terminal kinase [JNK]) was assessed on Western blots. Results and Conclusions: C3H10T1/2 cells constitutively synthesize BMP2 and 4 mRNA and protein, and this BMP activity is sufficient to activate basal levels of SMAD phosphorylation. Inhibition of BMP signaling was shown to disrupt the ability of RUNX2 to stimulate osteoblast differentiation and transactivate an osteocalcin gene promoter‐luciferase reporter in C3H10T1/2 cells. BMP blocking antibodies also inhibited RUNX2‐dependent osteoblast differentiation in primary cultures of murine marrow stromal cells. Conversely, RUNX2 expression synergistically stimulated BMP2 signaling in C3H10T1/2 cells. However, RUNX2 did not increase the ability of this BMP to activate SMAD, ERK, p38, and JNK pathways. This study shows that autocrine BMP production is necessary for the RUNX2 transcription factor to be active and that BMPs and RUNX2 cooperatively interact to stimulate osteoblast gene expression.Keywords
This publication has 61 references indexed in Scilit:
- The non-osteogenic mouse pluripotent cell line, C3H10T1/2, is induced to differentiate into osteoblastic cells by recombinant human bone morphogenetic protein-2Published by Elsevier ,2005
- Smad3 Interacts with JunB and Cbfa1/Runx2 for Transforming Growth Factor-β1-stimulated Collagenase-3 Expression in Human Breast Cancer CellsJournal of Biological Chemistry, 2004
- Transforming Growth Factor-β1 Regulation of Collagenase-3 Expression in Osteoblastic Cells by Cross-talk between the Smad and MAPK Signaling Pathways and Their Components, Smad2 and Runx2Published by Elsevier ,2004
- Activation of p38 Mitogen-Activated Protein Kinase and c-Jun-NH2-Terminal Kinase by BMP-2 and Their Implication in the Stimulation of Osteoblastic Cell DifferentiationJournal of Bone and Mineral Research, 2003
- A RUNX2/PEBP2αA/CBFA1 mutation in cleidocranial dysplasia revealing the link between the gene and SmadJournal of Bone and Mineral Metabolism, 2001
- Multilineage Differentiation of Cbfa1-Deficient Calvarial Cells in VitroBiochemical and Biophysical Research Communications, 2000
- Functional Hierarchy between Two OSE2 Elements in the Control of Osteocalcin Gene Expression in VivoJournal of Biological Chemistry, 1998
- Smad1 and Smad5 Act Downstream of Intracellular Signalings of BMP-2 That Inhibits Myogenic Differentiation and Induces Osteoblast Differentiation in C2C12 MyoblastsBiochemical and Biophysical Research Communications, 1997
- Bone Morphogenetic Protein-2 Causes Commitment and Differentiation in C3Hl0T1/2 and 3T3 CellsGrowth Factors, 1993
- Recombinant human bone morphogenetic protein-2 stimulates osteoblastic maturation and inhibits myogenic differentiation in vitro.The Journal of cell biology, 1991